Ariel Mundo Ortiz

Ariel Mundo Ortiz

Auto-generated profile, based on publicly available information

Ariel Mundo Ortiz

Department of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

27 August 2018 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
GGGage Greening
Gage Greening
AMAriel Mundo
Ariel Mundo
NRNarasimhan Rajaram
Narasimhan Rajaram
TMTimothy J. Muldoon
Timothy J. Muldoon
Diffuse reflectance spectroscopy (DRS) is a noninvasive, spectral biopsy technique that is used to indirectly estimate tissue optical properties and differentiate tissue types.1,2 The fundamental tissue optical properties are reduced scattering coefficient (μs′) and absorption coefficient (μa).3 The μs′ morphologically depends on the size, density, and orientation of scattering particles in tissue, such as the cell membrane, cell nuclei, mitochondria, lysosomes, and collagen fibers, among others.4,5 In amelanotic tissues, the μa in the visible and near infrared spectral ranges functionally depends on the total hemoglobin concentration and tissue oxygen saturation.3 Changes in these fundamental optical properties have been shown to occur in neoplastic and cancerous tissue because of angiogenesis, degradation of stromal collagen, and altered morphology of epithelial cells.5 6. – 7 Therefore, DRS has shown promise for early cancer diagnostics, tracking tissue response to therapy, and in intraoperative surgical guidance.1,2,8 9. 10. 11. – 12

6 March 2020 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
AMAriel I. Mundo
Ariel I. Mundo
GGGage J. Greening
Gage J. Greening
MFMichael J. Fahr
Michael J. Fahr
LHLawrence N. Hale
Lawrence N. Hale
EBElizabeth A. Bullard
Elizabeth A. Bullard
TMTimothy J. Muldoon
Timothy J. Muldoon
Colorectal cancer (CRC) is the fourth leading cause of cancer death in the world, and in the United States, it accounted for 145,600 new cases in 2019.1,2 Preclinical research aimed at understanding the mechanisms of this disease and developing new therapies, frequently focuses on the use of ectopic xenografts or allografts in murine models to study molecular shifts in tumors.3 – 5 However, these xenograft/allograft animal models do not properly take into account the influence of the tumor microenvironment6 – 8 and lack predictive power regarding clinical phase II performance,9 which limits the inferences from the data obtained from them. Primary mouse models of CRC, which more closely replicate primary tumors seen in humans—tumors that develop from dysplastic lesions within the colon epithelium itself—resemble the tumor microenvironment and anatomic location, making them better suited for the study of this disease. These models can be derived via carcinogen administration—such as azoxymethane (AOM)—or in transgenic animals (such as APCmin).10

25 July 2022 in Neoplasia
Verified
Journal Article
Open access
AMAriel I. Mundo
Ariel I. Mundo
AMAbdussaboor Muhammad
Abdussaboor Muhammad
KBKerlin Balza
Kerlin Balza
CNChristopher E E Nelson
Christopher E E Nelson
TMTimothy J. Muldoon
Timothy J. Muldoon
Metronomic chemotherapy (MET) has been developed to address the shortcomings of maximum-tolerated chemotherapy (MTD) in regard to toxicity and development of resistance mechanisms in the tumor. In colorectal cancer (CRC), MET is a promising novel strategy to treat locally advanced malignancies when used as neoadjuvant chemotherapy (NAC). However, so far there are no preclinical studies to assess the impact of MET NAC in CRC to assess the benefits and challenges of this approach. Here, we used a primary model of CRC (via azoxymethane) to analyze longitudinal changes in angiogenesis in primary tumors under MET and MTD NAC using a combination of diffuse reflectance spectroscopy and mRNA expression (via qPCR). Our results show that MET and MTD NAC lead to increased mean tissue oxygen saturation (8% and 5%, respectively) and oxyhemoglobin (15% and 10%) between weeks 2 and 5 of NAC, and that such increases are caused by distinct molecular signatures in the angiogenic program. Specifically, we find that in the MET group there is a sustained increase in Hif-1a, Aldoa, and Pgk1 expression, suggesting upregulated glycolysis, whereas MTD NAC causes a significant reduction in the expression of the aforementioned genes and of Vegf, leading to vascular remodeling in MTD-treated tumors. Taken together, this study demonstrates the ability of combined optical and molecular methodologies to provide a holistic picture of tumor response to therapy in CRC in a minimally invasive manner.

18 September 2024 in Disaster Medicine and Public Health Preparedness
Verified
Journal Article
Open access
PDF file
FEFatima El-Mousawi
Fatima El-Mousawi
AOAriel Mundo Ortiz
Ariel Mundo Ortiz
RBRawda Berkat
Rawda Berkat
BNBouchra Nasri
Bouchra Nasri
Background: The frequency and severity of floods has increased in different regions of the world due to climate change. It is important to examine how adaptation measures impact the mental health of individuals affected by these disasters. Objective: The goal of this scoping review was to document the existing studies on the impact of flood adaptation measures in affected populations to identify the best preventive strategies and limitations that deserve further exploration. Methods: This study followed the PRISMA-ScR guidelines. Inclusion criteria focused on studies in English or French available in MEDLINE and Web of Science that examined the impact of adaptation measures on the mental health of flood victims. Literature reviews or non-study records were excluded from the analysis. Results: A total of 857 records were obtained from the examined databases. After 2 rounds of screening, 9 studies were included for full-text analysis. Six studies sought to identify the factors that drive resilience in flood victims, whereas 3 studies analyzed the impact of external interventions on their mental health. Conclusions: The limited number of studies demonstrates the need for public health policies to develop flood adaptation measures that can be used to support the mental health of flood victims.

11 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
AMAriel I. Mundo
Ariel I. Mundo
TMTimothy J. Muldoon
Timothy J. Muldoon
JTJohn R. Tipton
John R. Tipton
1 In biomedical research, the outcome of longitudinal studies has been traditionally analyzed using the repeated measures analysis of variance (rm-ANOVA) or more recently, linear mixed models (LMEMs). Although LMEMs are less restrictive than rm-ANOVA as they can work with unbalanced data and non-constant correlation between observations, both methodologies assume a linear trend in the measured response. It is common in biomedical research that the true trend response is nonlinear and in these cases the linearity assumption of rm-ANOVA and LMEMs can lead to biased estimates and unreliable inference. In contrast, GAMs relax the linearity assumption of rm-ANOVA and LMEMs and allow the data to determine the fit of the model while also permitting incomplete observations and different correlation structures. Therefore, GAMs present an excellent choice to analyze longitudinal data with non-linear trends in the context of biomedical research. This paper summarizes the limitations of rm-ANOVA and LMEMs and uses simulated data to visually show how both methods produce biased estimates when used on data with non-linear trends. We present the basic theory of GAMs and using reported trends of oxygen saturation in tumors, we simulate example longitudinal data (2 treatment groups, 10 subjects per group, 5 repeated measures for each group) to demonstrate their implementation in R. We also show that GAMs are able to produce estimates with non-linear trends even when incomplete observations exist (with 40% of the simulated observations missing). To make this work reproducible, the code and data used in this paper are available at: https://github.com/aimundo/GAMs-biomedical-research .